Expert Opinion on Investigational Drugs 2001-08-01

A daughter of bradykinin that protects against septicaemia.

S A Doggrell

文献索引：Expert Opin. Investig. Drugs 10(8) , 1567-9, (2001)

全文：HTML全文

摘要

When the defence response of the body to infectious bacteria fails, septic shock ensues with hypotension and death. RPPGF,(1-5)-bradykinin, was until recently considered to be an active metabolite of bradykinin. In an animal model of septicaemia (lipopolysaccharide administration to rats), RPPGF is protective, and can even prolong life. RPPGF, or stable mimetics, have potential in the treatment of septic shock.